Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Adenosine A2b Receptor Protein (ADORA2B) (His tag)

ADORA2B Origin: Mouse Host: Escherichia coli (E. coli) Recombinant > 97 % SDS, WB, Imm, PC
Catalog No. ABIN7408366
  • Target See all Adenosine A2b Receptor (ADORA2B) Proteins
    Adenosine A2b Receptor (ADORA2B)
    Protein Type
    Recombinant
    Origin
    • 5
    • 2
    Mouse
    Source
    • 2
    • 2
    • 2
    • 1
    Escherichia coli (E. coli)
    Purification tag / Conjugate
    This Adenosine A2b Receptor protein is labelled with His tag.
    Application
    SDS-PAGE (SDS), Western Blotting (WB), Immunogen (Imm), Positive Control (PC)
    Characteristics
    Recombinant Adenosine A2b Receptor (ADORA2b), Prokaryotic expression, , N-terminal His Tag
    Purity
    > 97 %
    Top Product
    Discover our top product ADORA2B Protein
  • Application Notes
    Optimal working dilution should be determined by the investigator.
    Comment

    Isoelectric Point:

    Restrictions
    For Research Use only
  • Format
    Lyophilized
    Buffer
    PBS, pH 7.4, containing 0.01 % SKL, 1 mM DTT, 5 % Trehalose and Proclin300.
    Preservative
    ProClin
    Precaution of Use
    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Storage
    4 °C,-80 °C
    Storage Comment
    Store at 2-8°C for one month. Aliquot and store at -80°C for 12 months.
    Expiry Date
    12 months
  • Target
    Adenosine A2b Receptor (ADORA2B)
    Alternative Name
    Adenosine A2b Receptor (ADORA2B Products)
    Synonyms
    si:dkey-13b16.1 Protein, ADORA2B Protein, LOC606745 Protein, LOC100220469 Protein, ADORA2 Protein, A2BAR Protein, A2BR Protein, A2b Protein, AA2BR Protein, AI480866 Protein, AI605384 Protein, adenosine A2b receptor Protein, adenosine A2B receptor Protein, adora2b Protein, ADORA2B Protein, Adora2b Protein
    Pathways
    cAMP Metabolic Process, Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process
You are here: